- Home
- Equipment
- canada alberta
- clinical trial
Refine by
Clinical Trial Equipment Supplied In Canada Alberta
6 equipment items found
Manufactured by:Hemostemix Inc. based inCalgary, ALBERTA (CANADA)
Hemostemix is currently conducting a randomized, double-blind, placebo-controlled Phase 2 clinical trial for patients with critical limb ischemia at sites in the Canada and United ...
by:Forest Devices based inPittsburgh, PENNSYLVANIA (USA)
Forest Devices has developed a disruptive technology: the first objective, electronically-determined test for stroke for use by EMS. shown an increase in diagnostic accuracy of 92% in pilot clinical trials of nearly 300 people expected to reduce — and possibly eliminate in some cases — disabilities, rehabilitation costs and even death from stroke ...
by:Enveric Biosciences, Inc. based inNaples, FLORIDA (USA)
Enveric Biosciences seeks to advance novel combinations of CBD with chemotherapeutic agents and immunotherapies. Preclinical data suggests combination therapies may improve the activity of certain chemotherapies or cancer immunotherapies, potentially enabling more potent or longer-lasting therapeutic effects. In addition, combination therapies may allow for the same or greater therapeutic effect ...
Manufactured by:Nanostics Inc. based inEdmonton, ALBERTA (CANADA)
Our lead product, ClarityDx Prostate® is designed to be a highly accurate test to assist in diagnosing clinically significant prostate cancer and improve prostate healthcare decisions. Validation of ClarityDX Prostate® is ongoing in a 2800 patient clinical study designed to meet regulatory ...
Manufactured by:Nanostics Inc. based inEdmonton, ALBERTA (CANADA)
Our core technology ClarityDX® can: Identify biomarkers expressed by diseased cells/tissues. Indicate if treatment is needed. Predict treatment response and resistance. Stratify disease stage. Identify disease ...
Manufactured by:Hemostemix Inc. based inCalgary, ALBERTA (CANADA)
Hemostemix’s technology uses a patient’s own cells to treat that patient’s disease. The cornerstone of this autologous technology is a novel cell population within the blood called the synergetic cell population (SCP). The synergetic cell population, which can be collected from a simple blood draw, consists of progenitor and other supporting cells that are being developed for ...